US Stock MarketDetailed Quotes
PAVMZ Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z
- 0.0275
- 0.00000.00%
Close Nov 14 09:56 ET
366.94KMarket Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0275Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)13.34MShares0.180052wk High0.00P/B366.94KFloat Cap0.011352wk Low--Dividend TTM13.34MShs Float8.0700Historical High--Div YieldTTM0.00%Amplitude0.0012Historical Low--Avg Price1Lot Size
Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 489.76%979K | 126.46%1.01M | 550.40%2.45M | 836.61%1.05M | 940.79%791K | 166K | 135.98%446K | -24.60%377K | -62.67%112K | -62.00%76K |
| Operating revenue | 489.76%979K | 126.46%1.01M | 550.40%2.45M | 836.61%1.05M | 940.79%791K | --166K | 135.98%446K | -24.60%377K | -62.67%112K | -62.00%76K |
| Cost of revenue | -1.13%1.67M | 29.57%1.74M | 77.64%6.42M | -0.43%1.61M | 9.41%1.78M | 1.69M | 264.77%1.35M | 517.78%3.61M | 266.89%1.62M | 1,029.17%1.63M |
| Gross profit | 54.77%-687K | 18.44%-734K | -22.58%-3.97M | 62.68%-562K | 36.26%-988K | -1.52M | -400.00%-900K | -3,708.24%-3.24M | -968.09%-1.51M | -2,867.86%-1.55M |
| Operating expense | -13.15%13M | -31.79%13.3M | -26.21%64.83M | -31.50%15.82M | -33.35%14.54M | -36.28%14.97M | 0.24%19.5M | 61.76%87.85M | 18.21%23.1M | 58.97%21.82M |
| Selling and administrative expenses | 2.37%11.25M | -26.48%10.99M | -20.09%48.53M | -26.35%11.72M | -28.03%10.87M | -31.71%10.99M | 11.54%14.95M | 76.97%60.73M | 27.87%15.92M | 79.84%15.11M |
| -Selling and marketing expense | -2.24%4.24M | -5.02%4.31M | -8.98%17.58M | -18.56%4.69M | -15.20%4.02M | -11.41%4.34M | 15.64%4.54M | 117.18%19.32M | 72.43%5.76M | 106.54%4.74M |
| -General and administrative expense | 5.37%7.01M | -35.83%6.68M | -25.27%30.95M | -30.77%7.03M | -33.89%6.86M | -40.59%6.65M | 9.84%10.41M | 62.90%41.41M | 11.53%10.16M | 69.82%10.37M |
| Research and development costs | -52.70%1.64M | -52.07%1.94M | -43.66%14.28M | -46.13%3.6M | -49.03%3.16M | -48.53%3.47M | -31.73%4.05M | 27.67%25.34M | -4.23%6.67M | 16.91%6.2M |
| Depreciation amortization depletion | -79.21%105K | -26.34%372K | 13.28%2.02M | -0.20%505K | 0.00%505K | -22.31%505K | 310.57%505K | 1,121.92%1.78M | 311.38%506K | 2,870.59%505K |
| -Depreciation and amortization | -79.21%105K | -26.34%372K | 13.28%2.02M | -0.20%505K | 0.00%505K | -22.31%505K | 310.57%505K | 1,121.92%1.78M | 311.38%506K | 2,870.59%505K |
| Operating profit | 16.99%-13.68M | 31.20%-14.04M | 24.47%-68.8M | 33.41%-16.38M | 33.55%-15.53M | 29.81%-16.48M | -3.90%-20.4M | -67.46%-91.09M | -25.01%-24.6M | -70.96%-23.37M |
| Net non-operating interest income expense | 252.31%99K | 190.32%56K | 92.45%-84K | 161.90%78K | 92.57%-35K | 87.40%-65K | -3,200.00%-62K | -1.11M | -126K | -471K |
| Non-operating interest income | -32.52%110K | -40.50%72K | 198.82%505K | -8.49%97K | 129.63%124K | 2,228.57%163K | 5,950.00%121K | --169K | --106K | --54K |
| Non-operating interest expense | -95.18%11K | -91.26%16K | -54.02%589K | -91.81%19K | -69.71%159K | -56.41%228K | --183K | --1.28M | --232K | --525K |
| Other net income (expense) | 1.04%-1.33M | -158.82%-4.53M | 5.93%-10.38M | -811.61%-1.1M | -1.53%-6.19M | 73.67%-1.34M | -1.75M | -536.99%-11.04M | 155K | -6.09M |
| Gain on sale of security | 5.67%-566K | -107.98%-2.16M | -404.01%-6.42M | ---6.13M | ---31K | 70.00%-600K | ---1.04M | -175.68%-1.27M | ---- | ---- |
| Special income (charges) | -2.69%-763K | -598.74%-2.37M | 48.80%-2.78M | -141.16%-750K | 65.57%-1.76M | ---743K | --475K | -59.12%-5.43M | ---311K | ---5.12M |
| -Less:Other special charges | 2.69%763K | 351.24%2.37M | -30.40%3.78M | 141.16%750K | -65.57%1.76M | --743K | --525K | 59.12%5.43M | --311K | --5.12M |
| -Gain on sale of property,plant,equipment | --0 | --0 | --1M | --0 | --0 | --0 | --1M | --0 | --0 | --0 |
| Other non- operating income (expenses) | ---- | ---- | 72.62%-1.19M | 231.91%5.77M | -352.32%-4.39M | ---- | ---1.19M | ---4.33M | --1.74M | ---971K |
| Income before tax | 16.64%-14.91M | 16.67%-18.51M | 23.22%-79.26M | 29.16%-17.41M | 27.34%-21.75M | 38.52%-17.89M | -13.15%-22.21M | -83.94%-103.24M | -24.86%-24.57M | -118.99%-29.93M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 16.64%-14.91M | 16.67%-18.51M | 23.22%-79.26M | 29.16%-17.41M | 27.34%-21.75M | 38.52%-17.89M | -13.15%-22.21M | -83.94%-103.24M | -24.86%-24.57M | -118.99%-29.93M |
| Net income continuous Operations | 16.64%-14.91M | 16.67%-18.51M | 23.22%-79.26M | 29.16%-17.41M | 27.34%-21.75M | 38.52%-17.89M | -13.15%-22.21M | -83.94%-103.24M | -24.86%-24.57M | -118.99%-29.93M |
| Minority interest income | -21.82%-4.09M | 22.95%-3.3M | -5.84%-15.09M | 18.00%-3.37M | -7.17%-4.08M | 6.18%-3.36M | -55.12%-4.28M | -146.67%-14.26M | -67.09%-4.11M | -164.12%-3.81M |
| Net income attributable to the parent company | 25.52%-10.83M | 15.16%-15.21M | 27.88%-64.18M | 31.40%-14.04M | 32.36%-17.67M | 43.05%-14.54M | -6.28%-17.93M | -76.74%-88.98M | -18.83%-20.46M | -113.67%-26.13M |
| Preferred stock dividends | 8.00%81K | 10,137.84%7.58M | 8.19%304K | 8.33%78K | 8.45%77K | 7.14%75K | 8.82%74K | -0.71%281K | 7.46%72K | 5.97%71K |
| Other preferred stock dividends | 1.79M | 0 | ||||||||
| Net income attributable to common stockholders | 25.35%-10.91M | -26.56%-22.79M | 25.76%-66.27M | 22.54%-15.91M | 32.25%-17.75M | 42.91%-14.61M | -6.29%-18.01M | -76.31%-89.26M | -18.79%-20.53M | -113.09%-26.2M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data